Samsung Biologics to acquire PolyPeptide Group for KRW2.706T
Samsung Biologics plans to acquire 100% of PolyPeptide Group for KRW2.706T.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.